Clinical Trials for ISA Pharmaceuticals

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ISA Pharmaceuticals

Clinical Trials (4)

NCT05841095
Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
PHASE1/PHASE2Recruiting
24 participants
Started: Aug 4, 2023 · Completed: Nov 1, 2025
1 condition2 sponsors1 location
NCT04398524
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
PHASE2Active, not recruiting
65 participants
Started: Jul 1, 2021 · Completed: Dec 30, 2024
1 condition2 sponsors41 locations
NCT04369937
"HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for Intermediate Risk HPV-16-associated Head and Neck Squamous Cell Carcinoma"
PHASE2Active, not recruiting
18 participants
Started: Jul 6, 2020 · Completed: Jan 15, 2026
2 conditions3 sponsors1 location
NCT03669718
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
PHASE2Active, not recruiting
194 participants
Started: Nov 30, 2018 · Completed: Jun 30, 2025
2 conditions2 sponsors44 locations